标题
The RANK–RANKL axis: an opportunity for drug repurposing in cancer?
作者
关键词
Checkpoint, Denosumab, Immunotherapy, Osteoprotegerin, RANK, RANKL
出版物
Clinical & Translational Oncology
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2019-01-17
DOI
10.1007/s12094-018-02023-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The anti-tumor effect of RANKL inhibition in malignant solid tumors – A systematic review
- (2018) A.F. de Groot et al. CANCER TREATMENT REVIEWS
- An Observational Study of Concomitant Use of Emerging Therapies and Denosumab or Zoledronic Acid in Prostate Cancer
- (2018) Alexander Liede et al. CLINICAL THERAPEUTICS
- LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells
- (2018) Zhiying Yue et al. FASEB JOURNAL
- RANKL Signaling Sustains Primary Tumor Growth in Genetically Engineered Mouse Models of Lung Adenocarcinoma
- (2018) Julien Faget et al. Journal of Thoracic Oncology
- RANKL and RANK: From Mammalian Physiology to Cancer Treatment
- (2018) Shuan Rao et al. TRENDS IN CELL BIOLOGY
- Influence of estrogen in non-small cell lung cancer and its clinical implications
- (2018) Vianey Rodriguez-Lara et al. Journal of Thoracic Disease
- RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancer
- (2018) Elizabeth Ahern et al. OncoImmunology
- An observational study of concomitant immunotherapies and denosumab in patients with advanced melanoma or lung cancer
- (2018) Alexander Liede et al. OncoImmunology
- Adjuvant denosumab in early breast cancer: Disease-free survival analysis of 3,425 postmenopausal patients in the ABCSG-18 trial.
- (2018) Michael Gnant et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant denosumab in early breast cancer: First results from the international multicenter randomized phase III placebo controlled D-CARE study.
- (2018) Robert E. Coleman et al. JOURNAL OF CLINICAL ONCOLOGY
- Receptor activator of NF-κB (RANK)-mediated induction of metastatic spread and association with poor prognosis in renal cell carcinoma
- (2018) André Steven et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Poster Abstracts
- (2018) EUROPEAN JOURNAL OF CANCER
- RANK rewires energy homeostasis in lung cancer cells and drives primary lung cancer
- (2017) Shuan Rao et al. GENES & DEVELOPMENT
- Leucine-rich repeat–containing G protein–coupled receptor 4 (Lgr4) is necessary for prostate cancer metastasis via epithelial–mesenchymal transition
- (2017) Weijia Luo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial
- (2017) James L Gulley et al. LANCET ONCOLOGY
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Denosumab: Current Use in the Treatment of Primary Bone Tumors
- (2017) Olga D. Savvidou et al. ORTHOPEDICS
- Evaluation of the Prognostic Value of RANK, OPG, and RANKL mRNA Expression in Early Breast Cancer Patients Treated with Anthracycline-Based Adjuvant Chemotherapy
- (2017) Eleni Timotheadou et al. Translational Oncology
- The RANK/RANKL/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy
- (2017) Mekonnen Sisay et al. OncoTargets and Therapy
- Overexpression of a functional calcium-sensing receptor dramatically increases osteolytic potential of MDA-MB-231 cells in a mouse model of bone metastasis through epiregulin-mediated osteoprotegerin downregulation
- (2017) Cédric Boudot et al. Oncotarget
- RANKL-induced M1 macrophages are involved in bone formation
- (2017) Rong Huang et al. Bone Research
- Muscle RANK is a key regulator of Ca2+ storage, SERCA activity, and function of fast-twitch skeletal muscles
- (2016) Sébastien S. Dufresne et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- RANK-RANKL signalling in cancer
- (2016) N. Renema et al. BIOSCIENCE REPORTS
- Can we prevent BRCA1-associated breast cancer by RANKL inhibition?
- (2016) Joanne Kotsopoulos et al. BREAST CANCER RESEARCH AND TREATMENT
- Regulatory T cells in cancer immunotherapy
- (2016) Atsushi Tanaka et al. CELL RESEARCH
- RANK as a therapeutic target in cancer
- (2016) Eva González-Suárez et al. FEBS Journal
- Combination Anti-CTLA-4 and Anti-RANKL in Metastatic Melanoma
- (2016) Mark J. Smyth et al. JOURNAL OF CLINICAL ONCOLOGY
- Toward Repurposing Metformin as a Precision Anti-Cancer Therapy Using Structural Systems Pharmacology
- (2016) Thomas Hart et al. Scientific Reports
- New Insights into the Crossroads between EMT and Stemness in the Context of Cancer
- (2016) Isabel Fabregat et al. Journal of Clinical Medicine
- Repurposing medicinal compounds for blood cancer treatment
- (2015) Bronagh McCabe et al. ANNALS OF HEMATOLOGY
- RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs
- (2015) B Beuselinck et al. BRITISH JOURNAL OF CANCER
- Receptor activating NF-κB ligand (RANKL) is a constitutive intracellular protein in resting human basophils and is strongly induced on their surface by interleukin 3
- (2015) Caroline Poli et al. IMMUNOBIOLOGY
- Receptor Activator of NF-κB Ligand Promotes the Production of CCL17 from RANK+ M2 Macrophages
- (2015) Taku Fujimura et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Drug repurposing in oncology—patient and health systems opportunities
- (2015) Francesco Bertolini et al. Nature Reviews Clinical Oncology
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- RANK pathway in giant cell tumor of bone: pathogenesis and therapeutic aspects
- (2015) Pan-Feng Wu et al. TUMOR BIOLOGY
- Receptor activator of nuclear factor κB expression is a prognostic factor in human osteosarcoma
- (2015) KLEMENS TRIEB et al. Oncology Letters
- Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche
- (2015) Michelle A. Lawson et al. Nature Communications
- Cervical (pre)neoplastic microenvironment promotes the emergence of tolerogenic dendritic cells via RANKL secretion
- (2015) Stéphanie A Demoulin et al. OncoImmunology
- Enhancement of an anti-tumor immune response by transient blockade of central T cell tolerance
- (2014) Imran S. Khan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- NF- B, an Active Player in Human Cancers
- (2014) Y. Xia et al. Cancer Immunology Research
- Effects of RANKL-Targeted Therapy in Immunity and Cancer
- (2014) Michael L. Cheng et al. Frontiers in Oncology
- GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer
- (2013) Jinhua Wu et al. CARCINOGENESIS
- RANK expression on breast cancer cells promotes skeletal metastasis
- (2013) Michelle L. Blake et al. CLINICAL & EXPERIMENTAL METASTASIS
- Activated human T cells express alternative mRNA transcripts encoding a secreted form of RANKL
- (2013) N C Walsh et al. GENES AND IMMUNITY
- Immunology and bone
- (2013) L. Danks et al. JOURNAL OF BIOCHEMISTRY
- Differential Expression of the RANKL/RANK/OPG System Is Associated with Bone Metastasis in Human Non-Small Cell Lung Cancer
- (2013) Xianbo Peng et al. PLoS One
- Progesterone/RANKL Is a Major Regulatory Axis in the Human Breast
- (2013) T. Tanos et al. Science Translational Medicine
- Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis
- (2013) Pasquale Pellegrini et al. STEM CELLS
- Where Do Bone-Targeted Agents RANK in Breast Cancer Treatment?
- (2013) Roger von Moos et al. Journal of Clinical Medicine
- RANK Induces Epithelial-Mesenchymal Transition and Stemness in Human Mammary Epithelial Cells and Promotes Tumorigenesis and Metastasis
- (2012) M. Palafox et al. CANCER RESEARCH
- Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid: Subgroup Analysis from a Randomized Phase 3 Study
- (2012) Giorgio Vittorio Scagliotti et al. Journal of Thoracic Oncology
- RANKL Expression Specifically Observed in Vivo Promotes Epithelial Mesenchymal Transition and Tumor Progression
- (2011) Tamaki Yamada et al. AMERICAN JOURNAL OF PATHOLOGY
- Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?
- (2011) R E Langley et al. BRITISH JOURNAL OF CANCER
- The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells
- (2011) M. Shin et al. CARCINOGENESIS
- Molecular Pathways: Osteoclast-Dependent and Osteoclast-Independent Roles of the RANKL/RANK/OPG Pathway in Tumorigenesis and Metastasis
- (2011) W. C. Dougall CLINICAL CANCER RESEARCH
- RANKL/RANK—beyond bones
- (2011) Reiko Hanada et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
- (2011) Matthew R Smith et al. LANCET
- Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signalling
- (2011) Wei Tan et al. NATURE
- Receptor Activator of NF-kB (RANK) Expression in Primary Tumors Associates with Bone Metastasis Occurrence in Breast Cancer Patients
- (2011) Daniele Santini et al. PLoS One
- Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study
- (2010) David Thomas et al. LANCET ONCOLOGY
- RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis
- (2010) Eva Gonzalez-Suarez et al. NATURE
- Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer
- (2010) Daniel Schramek et al. NATURE
- RANK-RANKL Signaling Pathway Is Critically Involved in the Function of CD4 + CD25 + Regulatory T Cells in Chronic Colitis
- (2009) Teruji Totsuka et al. JOURNAL OF IMMUNOLOGY
- Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma
- (2009) Etienne Meylan et al. NATURE
- Receptor activator of NF-κB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells
- (2008) Valerie A Odero-Marah et al. CELL RESEARCH
- The Tumor Necrosis Factor Family Receptors RANK and CD40 Cooperatively Establish the Thymic Medullary Microenvironment and Self-Tolerance
- (2008) Taishin Akiyama et al. IMMUNITY
- RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis
- (2008) R. E. Miller et al. MOLECULAR CANCER THERAPEUTICS
- NK cells and cancer immunosurveillance
- (2008) I Waldhauer et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started